Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Effect of verapamil (isoptin) on kidney function]

E B Berkhin, V V Gurevich

    Farmakologiia I Toksikologiia
    |January 1, 1980
    PubMed
    Summary

    This study investigates how the medication verapamil influences kidney function, specifically looking at urine production, sodium excretion, and how the kidneys filter blood in animal models. The researchers observed different effects depending on whether the drug was given into the general circulation or directly into the kidney's blood supply.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Beyond traditional pharmacology: new tools and approaches.

    British journal of pharmacology·2015
    Same author

    Caspase-cleaved arrestin-2 and BID cooperatively facilitate cytochrome C release and cell death.

    Cell death and differentiation·2013
    Same author

    Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder.

    Neurobiology of disease·2011
    Same author

    Arrestin-1 expression level in rods: balancing functional performance and photoreceptor health.

    Neuroscience·2010
    Same author

    Dynamics of mouse rod phototransduction and its sensitivity to variation of key parameters.

    IET systems biology·2009
    Same author

    Arrestins as multi-functional signaling adaptors.

    Handbook of experimental pharmacology·2008

    Area of Science:

    • Renal physiology and verapamil pharmacology research
    • Systemic hemodynamics within nephrology

    Background:

    The precise impact of calcium channel blockers on renal hemodynamics remains a subject of ongoing investigation. Prior research has shown that systemic administration of these agents often alters blood flow patterns. That uncertainty drove researchers to examine how specific delivery routes influence kidney performance. It was already known that renal filtration processes are highly sensitive to vascular tone changes. This gap motivated a detailed assessment of how drug delivery sites modify physiological outcomes. No prior work had resolved the distinct responses observed between systemic and local renal arterial infusion. Scientists have long sought to clarify the mechanisms governing tubular reabsorption under pharmacological stress. These investigations provide a foundation for understanding how therapeutic agents interact with complex renal regulatory systems.

    Purpose Of The Study:

    The aim of this study is to determine the effects of the calcium channel blocker on renal performance. Researchers sought to clarify how different administration routes modify the kidney's handling of water and sodium. This investigation addresses the uncertainty regarding the drug's impact on glomerular filtration and tubular reabsorption. The team examined whether systemic delivery produces the same physiological outcomes as localized renal arterial infusion. By comparing these methods, the authors intended to isolate the specific renal actions of the compound. This work explores the potential for site-specific modulation of kidney function. The motivation stems from the need to understand how pharmacological agents alter renal hemodynamics in conscious subjects. These experiments provide insight into the complex regulatory mechanisms governing urine production and electrolyte balance.

    Keywords:
    renal physiologynatriuresisdiuresisglomerular filtration

    Frequently Asked Questions

    The researchers propose that systemic delivery reduces filtration and sodium output, whereas direct renal artery infusion increases them by blocking tubular reabsorption. This mechanism contrasts with the initial suppression seen when the drug enters general circulation.

    The study utilized conscious dogs and rats to observe physiological changes. These animal models allow for the assessment of diuresis and natriuresis under controlled conditions without the confounding influence of anesthesia on renal blood flow.

    Direct infusion into the renal artery is necessary to isolate the drug's effect on tubular reabsorption from systemic hemodynamic changes. This technique allows researchers to observe increased sodium excretion without the initial decrease in glomerular filtration seen systemically.

    The researchers measured diuresis, natriuresis, and glomerular filtration rates. These metrics provide a comprehensive view of how the drug alters both the filtration capacity of the kidney and the subsequent processing of water and electrolytes.

    Related Experiment Videos

    Main Methods:

    Review approach involved administering the compound to conscious canine subjects at doses of three to four milligrams per kilogram. Investigators utilized intravenous routes to assess systemic responses on filtration and electrolyte excretion. The team also performed direct infusions into the renal artery to evaluate localized physiological changes. Researchers monitored diuresis and natriuresis throughout the duration of the experimental procedures. In a separate cohort, the scientists treated rats with doses ranging from five to ten milligrams per kilogram. This design allowed for the comparison of dose-dependent responses across different mammalian species. The study tracked the temporal progression of renal parameters following drug delivery. Data collection focused on identifying shifts in filtration rates and tubular activity.

    Main Results:

    Key findings from the literature indicate that systemic administration of the agent at three to four milligrams per kilogram initially reduces diuresis and natriuresis. The glomerular filtration rate also decreases following intravenous delivery in the canine model. Over time, the filtration rate returns to baseline levels while urine and sodium output increase. Direct infusion into the renal artery enhances both diuresis and natriuresis by inhibiting tubular reabsorption. In rats, doses of five to ten milligrams per kilogram trigger a rise in sodium excretion and urine volume. However, the rat subjects exhibit an initial reduction in water diuresis before the increase occurs. These results demonstrate that the delivery route significantly alters the renal response profile. The evidence confirms that the drug exerts varying effects on kidney performance based on the site of administration.

    Conclusions:

    The authors propose that systemic delivery of the agent initially suppresses filtration and sodium excretion. Synthesis and implications suggest that local infusion into the renal artery produces a distinct diuretic effect. This shift occurs because the drug inhibits normal tubular reabsorption processes within the kidney. Observations in rats confirm that the medication promotes sodium excretion despite initial water retention. The researchers indicate that the route of administration dictates the overall renal response. These findings highlight the complexity of drug-induced changes in kidney function. The data suggest that local vascular delivery bypasses systemic inhibitory effects on filtration. Future clinical applications must account for these site-specific physiological variations.

    The researchers observed that rats experienced an initial reduction in water diuresis followed by a rise in sodium excretion. This biphasic response differs from the immediate systemic effects documented in the canine subjects.

    The authors propose that the drug's ability to inhibit tubular reabsorption is the primary driver for increased urine production during local administration. This claim suggests that the site of action is localized to the renal tubules.